Ichor Life Sciences

Ichor Life Sciences is a privately held, revenue-generating contract research organization (CRO) headquartered in Buffalo, New York. It operates as a full-service partner for drug R&D, offering integrated services from gene-to-structure analysis through in vivo disease modeling and clinical trial management. The company emphasizes scientific depth, customization, and an unconventional approach, including acceptance of cryptocurrency for services. Its activities indicate a strategic focus on decentralized science (DeSci) and early-stage investment in adjacent biotech startups.

Integrated CRO service platform spanning protein sciences (expression, purification, structural biology, biophysics), in vivo pharmacology (disease modeling, PK/PD, toxicology), and clinical trial support. Emphasizes deep fundamental assay expertise and high customizability.

Ichor competes in the large and fragmented pre-clinical CRO market against giants like Charles River Laboratories and Labcorp, as well as numerous specialty CROs. Its differentiation lies in its integrated 'gene-to-clinic' US-based services, deep scientific 'tool builder' culture, and unconventional business approaches like crypto transactions.